Early platelet and leukocyte decline in patients with neuroinflammatory disorders after intravenous immunoglobulins
Sign Up to like & getrecommendations! Published in 2017 at "European Journal of Neurology"
DOI: 10.1111/ene.13264
Abstract: Intravenous immunoglobulins (IVIGs) are a common therapy in patients with neuroinflammatory disorders, especially chronic inflammatory demyelinating polyradiculoneuropathy or Guillain−BarrĂ© syndrome. Hematological toxicities upon IVIG infusion are a known side effect and still an important subject… read more here.
Keywords: platelet leukocyte; leukocyte decline; intravenous immunoglobulins; patients neuroinflammatory ... See more keywords